http://www.physorg.com/ en-us Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine. A new study conducted at Ben-Gurion University of the Negev (BGU) reveals that Celebrex and other anti-inflammatory coxib medications may counter the positive effects of aspirin in preventing blood clots. http://www.physorg.com/news180806540.html Medicine & Health Wed, 23 Dec 2009 16:20:04 EST news180806540 Millions of Americans take Celebrex for arthritis or other pain. Many, if they are middle-aged or older, also take a low-dose aspirin tablet daily to reduce the risk of heart attack and stroke. Yet they may be getting little protection, because Celebrex keeps the aspirin from doing its job effectively, a new study suggests. http://www.physorg.com/news180040030.html Medicine & Health Mon, 14 Dec 2009 21:10:03 EST news180040030 With flu season in full swing and the threat of H1N1 looming, demand for vaccines is at an all-time high. Although those vaccines are expected to be effective, University of Missouri researchers have found further evidence that some over-the-counter drugs, such as aspirin and Tylenol, that inhibit certain enzymes could impact the effectiveness of vaccines. http://www.physorg.com/news178902940.html Medicine & Health Tue, 01 Dec 2009 15:30:01 EST news178902940 Since 1999, stroke survivors have been advised to use aspirin, prescription antiplatelet agents, or prescription anticoagulants to help avoid another stroke. Many large surveys of the U.S. population have reported the use of aspirin for secondary prevention, but commonly combine people with stroke and coronary artery disease, and only rarely report the use of antithrombotic agents other than aspirin. In an article published in the January 2010 issue of the American Journal of Preventive Medicine, researchers analyze survey data over a 7-year period to determine whether true usage of all preventive therapies, including aspirin, is increasing. http://www.physorg.com/news178896123.html Medicine & Health Tue, 01 Dec 2009 14:10:02 EST news178896123 Can treatments that reduce risks for cardiovascular disease (CVD) also help combat age-related macular degeneration (AMD), an eye disease that affects millions of Americans? CVD and AMD share some risk factors-such as smoking, high blood pressure, and inflammation-and a recent study found that people who have early-stage AMD are more likely to develop heart disease. This month's Ophthalmology, the journal of the American Academy of Ophthalmology, reports on how two heart disease treatments, low-dose aspirin and statin medications, may impact AMD risk and disease progression. http://www.physorg.com/news178892149.html Medicine & Health Tue, 01 Dec 2009 12:17:06 EST news178892149 For thousands of years it has been prescribed by traditional healers in Brazil to treat a range of ailments from headaches and stomach pain to fever and flu. http://www.physorg.com/news178315036.html Biology Tue, 24 Nov 2009 19:58:45 EST news178315036 A new study, published in the November 17, 2009, issue of the Journal of the American College of Cardiology, adds to a growing body of research seeking to evaluate and understand possible sex differences associated with antiplatelet therapies. This study--the first to look at the impact of clopidogrel, one of the most frequently prescribed drugs to prevent and treat heart disease, in women--found it to be effective in reducing cardiovascular (CV) events in both men and women with no statistically significant sex differences in terms of expected clinical benefit or increased harm. http://www.physorg.com/news177059069.html Medicine & Health Tue, 10 Nov 2009 08:00:03 EST news177059069 Unexpectedly, inflammation markers do not appear to be involved with the chemopreventative effect of aspirin on colorectal adenomas, according to a brief communication published online October 12 in the Journal of the National Cancer Institute. http://www.physorg.com/news174585295.html Medicine & Health Mon, 12 Oct 2009 17:40:02 EST news174585295 The devastation of the 1918-1919 influenza pandemic is well known, but a new article suggests a surprising factor in the high death toll: the misuse of aspirin. Appearing in the November 1 issue of Clinical Infectious Diseases and available online now, the article sounds a cautionary note as present day concerns about the novel H1N1 virus run high. http://www.physorg.com/news173715307.html Medicine & Health Fri, 02 Oct 2009 15:15:32 EST news173715307 Researchers at Monash University and the United States-based Berman Center for Outcomes & Clinical Research will lead an international clinical trial to test whether taking aspirin contributes to good health in the elderly. http://www.physorg.com/news173623617.html Medicine & Health Thu, 01 Oct 2009 14:00:01 EST news173623617 (PhysOrg.com) -- A daily dose of aspirin can prevent the occurrence of cancer in people with a genetic predisposition towards Lynch syndrome, a Newcastle University scientist has told Europe`s largest cancer congress. Lynch syndrome is a condition which accounts for around 5 per cent of all colon cancers. http://www.physorg.com/news173369935.html Medicine & Health Mon, 28 Sep 2009 15:40:02 EST news173369935 (AP) -- People with a genetic susceptibility to colon cancer could cut their chances of developing the disease in half by taking a daily dose of aspirin, researchers said Monday. http://www.physorg.com/news172735446.html Medicine & Health Mon, 21 Sep 2009 07:20:20 EST news172735446 Men and women who were diagnosed with colorectal cancer and began regular use of aspirin had a lower risk of overall and colorectal cancer death compared to patients not using aspirin, according to a study in the August 12 issue of JAMA. http://www.physorg.com/news169225524.html Medicine & Health Tue, 11 Aug 2009 16:06:46 EST news169225524 Heart disease patients with previous atherosclerosis (fat deposits in the walls of the arteries) are more likely to die in the hospital and less likely to be treated with recommended therapies, researchers report in Circulation: Journal of the American Heart Association. http://www.physorg.com/news168540891.html Medicine & Health Mon, 03 Aug 2009 18:40:01 EST news168540891 (AP) -- Government experts called for sweeping safety restrictions Tuesday on the most widely used painkiller, including reducing the maximum dose of Tylenol and eliminating prescription drugs such as Vicodin and Percocet. http://www.physorg.com/news165598861.html Medicine & Health Tue, 30 Jun 2009 16:41:30 EST news165598861 (PhysOrg.com) -- A new study has shown that, while taking aspirin is beneficial in preventing heart attacks and strokes among people with established cardiovascular disease (secondary prevention), its benefits don`t clearly outweigh the risks in healthy people (primary prevention). http://www.physorg.com/news162820199.html Medicine & Health Fri, 29 May 2009 12:50:37 EST news162820199 Scientists are reporting discovery of a potential new alternative to aspirin, ReoPro, and other anti-platelet agents used widely to prevent blood clots in coronary artery disease, heart attack and stroke. Their study, scheduled for the June 23 issue of ACS Nano, a monthly journal, involves particles of silver -- 1/50,000th the diameter of a human hair -- that are injected into the bloodstream. http://www.physorg.com/news162666750.html Nanotechnology Wed, 27 May 2009 18:12:56 EST news162666750 Women with chest pain are less likely than male patients to receive recommended, proven therapies while en route to the hospital, according to new research from the University of Pennsylvania School of Medicine. Despite evidence showing that the drugs aspirin and nitroglycerin are important early interventions for people who may be having a heart attack, women don't get them as often as male patients with the same types of symptoms, says a new study that will be presented Friday, May 15, 2009 at the Society for Academic Emergency Medicine's annual conference. http://www.physorg.com/news161629752.html Medicine & Health Fri, 15 May 2009 18:09:44 EST news161629752 For many years, it has been known that aspirin is beneficial to patients suffering heart attacks and near-heart attacks. But which of the many different types of aspirin is likely to help the most? http://www.physorg.com/news161613270.html Medicine & Health Fri, 15 May 2009 13:36:19 EST news161613270 An analysis of previous studies indicates that among patients with peripheral artery disease, aspirin use is associated with a statistically nonsignificant decrease in the risk of a group of combined cardiovascular events (nonfatal heart attack, nonfatal stroke, and cardiovascular death), but is associated with a significant reduction in the risk of one of these events, nonfatal stroke, although the findings may be limited by the lack of a large study population, according to an article in the May 13 issue of JAMA. http://www.physorg.com/news161365561.html Medicine & Health Tue, 12 May 2009 16:46:23 EST news161365561 The Food and Drug Administration said Tuesday that it is asking drugmakers to more prominently display safety warnings on the labels of some of the most widely used over-the-counter pain and fever remedies. http://www.physorg.com/news160218973.html Medicine & Health Wed, 29 Apr 2009 10:16:39 EST news160218973 Individuals who take aspirin or other medications that prevent blood clotting by inhibiting the accumulation of platelets appear more likely to have tiny, asymptomatic areas of bleeding in the brain, according to a report posted online today that will appear in the June print issue of Archives of Neurology. http://www.physorg.com/news158863412.html Medicine & Health Mon, 13 Apr 2009 17:52:52 EST news158863412 (AP) -- Taking the blood thinner Plavix along with aspirin helped prevent strokes and heart attacks in people with a common heartbeat abnormality that puts them at high risk of these problems, doctors reported Tuesday. http://www.physorg.com/news157716473.html Medicine & Health Tue, 31 Mar 2009 11:08:23 EST news157716473 The President of the American College of Preventive Medicine commended the U.S. Preventive Services Task Force (USPSTF) today for its recommendations on aspirin use for primary prevention of heart attack and stroke, released in the March 17 issue of the Annals of Internal Medicine, citing its improved specificity over previous guidelines. http://www.physorg.com/news156518439.html Medicine & Health Tue, 17 Mar 2009 14:27:35 EST news156518439 New results from the Women's Health Initiative (WHI) Observational Study provide additional evidence that aspirin may reduce the risk of death in postmenopausal women who have heart disease or who have had a stroke. Jacques Rossouw, M.D., chief of the Women's Health Initiative Branch at the National Heart, Lung, and Blood Institute (NHLBI), is available to comment on these findings. NHLBI, part of the National Institutes of Health, funded the research. http://www.physorg.com/news156099931.html Medicine & Health Thu, 12 Mar 2009 18:06:24 EST news156099931 Resent studies reported that aspirin inhibited the growth of H. pylori in a dose-dependent manner and significantly affected the activity of virulence factors of H. pylori. In addition, aspirin increased the susceptibility of H. pylori to antimicrlbials including metronidazole, clarithromycin and amoxicillin. However, the mechanisms remained unknown. http://www.physorg.com/news155329433.html Medicine & Health Tue, 03 Mar 2009 19:08:20 EST news155329433 Following an acute coronary syndrome such as a heart attack or unstable angina, patients who receive a medication to reduce the risk of gastrointestinal bleeding that may be associated with the use of the antiplatelet drug clopidogrel and aspirin have an increased risk of subsequent hospitalization for acute coronary syndrome or death, according to a study in the March 4 issue of JAMA. http://www.physorg.com/news155320506.html Medicine & Health Tue, 03 Mar 2009 16:36:06 EST news155320506 Simple aspirin may prevent liver damage in millions of people suffering from side effects of common drugs, alcohol abuse, and obesity-related liver disease, a new Yale University study suggests. http://www.physorg.com/news152213055.html Medicine & Health Mon, 26 Jan 2009 17:24:50 EST news152213055 (PhysOrg.com) -- Exciting research into blood clotting by British Heart Foundation (BHF) researchers working at the University of Bristol will take us a step closer to better heart attack prevention and treatment. Blood clots can be both life-saving and life-threatening; life-saving when they stop bleeding, but life-threatening when they form in diseased arteries feeding the heart. Here they can cause a heart attack, and do so in 146,000 people in the UK every year. http://www.physorg.com/news151679743.html Medicine & Health Tue, 20 Jan 2009 13:16:09 EST news151679743 Despite considerable progress in modern chemotherapy, there remains a large demand for innovative anti-tumor agents. A new approach involves modeling the pharmacological properties of established drugs with organometallic fragments. As a team of scientists from Berlin and Bochum (Germany), Innsbruck (Austria), and Leiden (The Netherlands) report in the journal Angewandte Chemie, cobalt-aspirin complexes have potential as cytostatics. http://www.physorg.com/news151046764.html Chemistry Tue, 13 Jan 2009 05:26:04 EST news151046764